|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 15/115 | (2010.01) |
| A61K 31/7125 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 3385384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18156968.2 |
| Date of filing the European patent application | 2005-02-14 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (30) | Number | Date | Country code |
| 544542 P | 2004-02-12 | US | |
| 547747 P | 2004-02-25 | US | |
| 581685 P | 2004-06-21 | US | |
| 608048 P | 2004-09-07 | US |
| (72) |
Benedict, Claude, US
Diener, John, US
Epstein, David, US
Grate, Dilara, US
Keene, Sara Chesworth, US
Kurz, Jeffrey, US
Kurz, Markus, US
McCauley, Thomas Green, US
Rottman, James, US
Thompson, Kristin, US
Wilson, Charles, US
Zoltoski, Anna J., US
|
| (73) |
Archemix LLC,
601 Montgomery Street, Suite 2020, San Francisco, CA 94111,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Aptamero terapija, naudinga su komplementu susijusių ligų gydymui |
| APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2024-01-31 | 347.00 EUR |